Adjuvance Technologies Announces License and Collaboration
Adjuvance Technologies, a member of Bio Nebraska, announced it has licensed TQL-1055 to ClearB Therapeutics for use in a vaccine for Chronic Hepatitis B (CHB). Read more
Adjuvance Technologies, a member of Bio Nebraska, announced it has licensed TQL-1055 to ClearB Therapeutics for use in a vaccine for Chronic Hepatitis B (CHB). Read more
Rob Owen, the Executive Director of Bio Nebraska, was featured in the Midlands Business Journal to discuss opportunities for growth in biosciences and biomanufacturing in Nebraska. Read more
Bio Nebraska Executive Director, Rob Owen, was featured in an Omaha World-Herald article about the Edge District, the new name of UNMC’s Saddle Creek Development. Read more
For our October Member Spotlight, we talked to Virtual Incision, the winner of the 2024 Governor’s Bioscience Award. Read more
A recent Nebraska Examiner article by Hank Robinson discusses how Nebraska is uniquely positioned to lead the world in sustainable agriculture. Read more
Centese, a member of Bio Nebraska, shared their story recently with the Midlands Business Journal and talked about Thoraguard, its automated system for chest drainage after heart or lung surgery. Read more
Bio Nebraska announced today that Virtual Incision has been named the 2024 recipient of the Governor’s Bioscience Award. Read more
Viridis Chemical, a member of Bio Nebraska, has been named a winner of the EPA’s 2024 Green Chemistry Challenge Award. Read more
Join Bio Nebraska for a Bioscience Month celebration throughout the month of October. Read more
Bluestem Biosciences, a member of Bio Nebraska, received $2.16 million as part of the Department of Defense’s Distributed Bioindustrial Manufacturing Program. Read more